Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ et al (2021) Obesity and cardiovascular disease: a scientific statement from the american heart association
This is especially true for patients with thyroid history, gallbladder disease, pancreatitis risk, diabetes medications, gastrointestinal conditions, eating disorder history, hormone concerns, or significant muscle loss risk
These drugs are not without risk. The Drug Controller General of India continues to monitor the situation closely as the market expands following generic entry
Now, a new conversation is emerging: GLP-1 microdosing
Pre-surgical planning : Current UK guidance from the Centre for Perioperative Care (CPOC) and the Association of Anaesthetists indicates that most patients can continue GLP-1 receptor agonists like Ozempic before elective surgery
Zepbound: Lower Prices, Greater Competition Eli Lillys decision to lower the cost of Zepbound has already begun to broaden access for patients